Blood tests and colon cancer

Blood tests can reveal anaemia, check how organs are working, and provide a baseline before treatment. A tumour marker such as carcinoembryonic antigen, often shortened to CEA, may help monitor some people after diagnosis, but the result must be interpreted with scans, examination, pathology, and the clinical situation.

A full blood count may show anaemia, which can follow slow bleeding from the bowel but also has many other causes. Kidney and liver blood tests help clinicians plan imaging and treatment and may point to problems needing further assessment. None of these patterns identifies a bowel tumour by itself.

CEA is not a stand-alone screening test. Some colon cancers do not raise it, and non-cancerous conditions can affect the level. When it is useful for a particular patient, clinicians usually look at its pattern over time rather than treating one isolated value as proof of growth or response.

Review the result with the clinician who ordered it and ask which values matter in your situation. Report iron tablets, supplements, medicines, smoking, infection, inflammation, liver problems, and recent treatment because these details can affect interpretation.

If symptoms or screening results suggest a bowel problem, further assessment may involve stool testing, imaging, or colonoscopy. During colonoscopy, tissue can be sampled for pathology, which is how a suspected bowel cancer is confirmed. Keep appointments even if blood results are described as normal, because normal blood tests do not exclude a tumour.

Arrange a medical review for rectal bleeding, a persistent change in bowel habit, ongoing abdominal discomfort, unexplained weight loss, or continuing fatigue. Colon cancer can present with these symptoms, but each also has other possible causes that require proper assessment.

Seek urgent care for heavy bleeding, fainting, severe or rapidly worsening abdominal pain, repeated vomiting, black tar-like stool with weakness, or abdominal swelling with an inability to pass stool or gas. Urgency comes from the symptom pattern and severity, not from a tumour-marker reading.

Ask what each blood test was intended to check, whether a result needs repeating, and what non-cancer causes are being considered. If CEA is being monitored, ask what your baseline is, how trends will be interpreted, and which scan, examination, or symptom findings would change the plan.